The Latest Breaking News from FDA

These two growth stocks are attractive for investors seeking big upside in exchange for higher risk.

Health Secretary says expectant mothers should listen to doctors over US president on medical matters

The Trump administration has backed the use of leucovorin, a folate-based drug, for autism treatment. Here's what the science says, how it works, and why experts are divided on its effectiveness.

UK health bodies reaffirm paracetamol is safe in pregnancy after Trump autism claims. Experts warn misinformation could deter vital treatment.

Experts blast Trump's Tylenol-autism claims, stressing vaccines are safe and misinformation, not paracetamol, drives autism anxiety.

President Donald Trump caused a stir when he connected autism, acetaminophen (commonly known by the brand name Tylenol in the U.S.), and the island of Cuba during a White House announcement.

President Trump and his health team advise against taking Tylenol during pregnancy, rebuking long-standing public health guidance.

A Seattle seafood distributor has recalled more cooked and frozen shrimp sold at Kroger grocery stores across the U.S. because of ongoing concerns about potential radioactive contamination

The U.S. Food and Drug Administration (FDA) on Friday approved Merck Co. Inc.’s (NYSE:MRK) Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for Keytruda.

On Monday, the U.S. Food and Drug Administration (FDA) extended the review date for Sanofi SA’s (NASDAQ:SNY) new drug application (NDA) of tolebrutinib for non-relapsing, secondary progressive multiple sclerosis (nrSPMS) and to slow disability accumulation independent of relapse activity in adult patients.

For decades, a New York writer struggled to understand why she felt so stuck. It wasn't until she tried MDMA —and finally processed a dark episode from her past—that she got her answer.